This funding opportunity supports multidisciplinary bioengineering research that applies integrative approaches to solve biomedical problems. It funds design-directed, developmental, discovery-driven, or hypothesis-driven projects, including clinical trials that test functionality or validate performance. Phase III clinical trials and commercial production are excluded. Eligible applicants include diverse organizations, including foreign entities under specific conditions.
Eligible applicants include a wide range of organizations such as tribal governments, public housing authorities, educational institutions, nonprofits, small businesses, and state and local governments. Foreign organizations and non-domestic components of U.S. organizations may apply, but foreign co
